|Articles|February 11, 2021
- Pharmaceutical Executive-02-01-2021
- Volume 41
- Issue 2
Pharmaceutical Executive, February 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive February 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 5 years ago
Pharm Exec at 40about 5 years ago
A Vision of a Fairer Worldabout 5 years ago
Coupon-Program Pivot: Meeting New Legal, Operational Hurdlesabout 5 years ago
Digital-Communication Check: Insights Learned During Lockdownabout 5 years ago
The Best and the Worst on Display in Vaccine Effortabout 5 years ago
The Fight for Orphan Drug Research Reform in Europeabout 5 years ago
A ‘Golden Year’ for UK Life Sciences Sector?about 5 years ago
A Generational Opportunity for Talent Pipeline Developmentabout 5 years ago
Emotional Intelligence Can Help Lead Pharma Through Tough TimesNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5

